Home
Everest Engineering

Everest Engineering Market Share Analysis for May 2026

Our high-quality and flexible teams enable startups, scale-ups and established companies to build new products, transform their tech systems or define their strategy and innovation.

Industry: N/A

Domaineverest.engineering

Year Founded2018

Employees51 - 200

Annual Revenue--

Everest Engineering

Everest Engineering (including company regionals)

everest.engineering

See more website traffic and engagement information

Total visits to Everest Engineering's top domains

Understand Everest Engineering market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

everest.engineering1.6K

See more with Sales Intelligence

Avg. visit duration in Everest Engineering's top domains

Analyze Everest Engineering engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

everest.engineering00:00:08

See more with Sales Intelligence

Avg. pageviews on Everest Engineering's top domains

See how Everest Engineering keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

everest.engineering1.33

See more with Sales Intelligence

Everest Engineering top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Everest Engineering

These are the website technologies, by industry, used by Everest Engineering top domains

Advertising (3)

DoubleClick

Content Management System (2)

Medium

Email Services (2)

G Suite

Marketing (2)

Google Marketing Platform

More Technologies

6

See all

News & Signals from Everest Engineering

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEverest partnered with Kezar Life Sciences, Inc. on Aug 21st '23.Everest has recently announced a collaboration and licence agreement with Kezar Life Sciences to develop and commercialise Kezar's lead drug candidate, zetomipzomib, in Greater China, South Korea, and select Southeast Asian countries.